Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Unaudited financial ....

To Date: 13.08.2026 The Manager BSE Limited P. J. Towers, Dalal Street, Mumbai – 400001. Dear Sir/Madam, Sub: Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations, 2015. Unit: Vista Pharmaceuticals Limited (BE Scrip Code:524711) With reference to the subject cited, this is to inform the Exchange that meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited will be held on Friday, the 14th day of August, 2026 at the Registered office of the Company to consider the following: 1. Unaudited financial results for the quarter ended 30.06.2026 2. Limited Review Report for the quarter ended 30.06.2026 3. Any other business with the permission of the Chair. This isfor the information and records of the Exchange, please. Thanking You, Yours faithfully, For Vista Pharmaceuticals Limited Dhananjaya Alli Executive Director (DIN: 00610909)